trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
about
Resveratrol in prostate diseases - a short reviewMultiple molecular targets of resveratrol: Anti-carcinogenic mechanismsBroad targeting of angiogenesis for cancer prevention and therapyThe suppressive effect of resveratrol on HIF-1α and VEGF expression after warm ischemia and reperfusion in rat liverLXY6090 - a novel manassantin A derivative - limits breast cancer growth through hypoxia-inducible factor-1 inhibitionNatural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1).Identification of a novel small molecule HIF-1alpha translation inhibitor.Validation of anti-aging drugs by treating age-related diseases.Resveratrol preserves cerebrovascular density and cognitive function in aging mice.The effect of resveratrol on blood pressure in a rat model of preeclampsia.Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease.Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-cultureDauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1alpha protein accumulation and vascular endothelial growth factor expression in human breast cancer cellsModulation of inflammatory signaling pathways by phytochemicals in ovarian cancerIdentification and validation of Notch pathway activating compounds through a novel high-throughput screening method.Thermodynamic analysis of protein-ligand interactions in complex biological mixtures using a shotgun proteomics approach.Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic ratHigh Potency of a Novel Resveratrol Derivative, 3,3',4,4'-Tetrahydroxy-trans-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and RepairSignificance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells.Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1α in human ovarian cancer cell lines and a mouse ovarian cancer modelThe lifespan extension effects of resveratrol are conserved in the honey bee and may be driven by a mechanism related to caloric restrictionResveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization.High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation.The role of hypoxia inducible factor-1 in cell metabolism--a possible target in cancer therapy.Cancer and diet: How are they related?Plants and their active compounds: natural molecules to target angiogenesis.Dietary blueberry supplementation affects growth but not vascularization of neural transplants.Resveratrol inhibits proliferation of hypoxic choroidal vascular endothelial cells.Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease.Vanillin Suppresses Cell Motility by Inhibiting STAT3-Mediated HIF-1α mRNA Expression in Malignant Melanoma CellsLB-1 Exerts Antitumor Activity in Pancreatic Cancer by Inhibiting HIF-1α and Stat3 Signaling.Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2).Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells.Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome.Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells: calorie restriction is the force to the cytotoxicity.The Role of Resveratrol in Cancer Therapy.Beneficial Effects of Resveratrol-Mediated Inhibition of the mTOR Pathway in Spinal Cord Injury.
P2860
Q24601444-D9853158-E526-44C0-AA54-7D420F39622BQ24648759-6AF2AABC-2E8D-431C-9294-0D84B8190798Q27002903-E265C3B3-8E39-4D43-8945-902364D8A837Q28543622-7895B731-8B4E-41A8-BEF3-8F8BE7F835B1Q28828209-EDB6D252-CEA7-4805-A213-930B32FA1FB5Q33235403-1CFFADFE-028C-4144-97B9-4E2446924696Q33507488-62DF937E-8D40-4801-BB93-7F9B5427695FQ33588700-711E5B51-5084-42C8-BF3B-78E6655ABA85Q33868409-00E06488-9863-48C7-AB93-506D278F7956Q33994926-76F45457-A7B6-4F8F-B1B2-CD185E9ED171Q34150587-9789E144-30D8-4B86-8E6E-AF9FE9F4C6E3Q34306523-B456BAC8-1E38-48EA-8F25-3E6DC730D0CAQ34974514-9C888B80-46F6-4010-A003-5B5507CAE0B8Q34975827-BFE0E160-9324-44E6-ABB6-3524089687F0Q35050983-E2473BB7-BA3D-43BF-AABF-7C393140A3CEQ35529257-33EA201E-FC2D-4BDC-8D2D-34C89BCBEC9CQ35762325-4FB0BB8F-149D-4949-8C68-73BAF27137F8Q35851696-D9231B8E-9216-4FFD-BD3C-311AF2345934Q35954103-C3EED103-0C77-4F78-9B62-1CBA3CFE39A7Q36016357-97CEE589-6D23-4696-883E-7DBDD9B9D33DQ36105378-5BF236B3-7C3F-44DF-851C-7321E464EA58Q36209151-2AF23CEA-F42C-4B27-9691-D6638701ADBEQ36240204-C45C790E-5E87-4F76-A24A-1F5921B713DAQ36354166-C7164822-85AE-4AE4-95C5-8E244B3330CBQ36539483-F24C23EA-9492-4BC1-9A17-28F35D12D74BQ36587800-98EAD40F-A53B-4FC3-A138-4EC38D9A408DQ37059810-EE2AC453-B32B-4DA3-ADD8-9EC37A5DE94CQ37217013-F3D314D3-E30F-4F0F-BEF5-21CDA06669B7Q37363964-DEC3081F-FB16-4E26-9172-FB9C5B76BB04Q37445518-5CD95DA3-099F-48AE-AF05-48FEBCA4C2C1Q37729094-D21CFFCF-6BF2-4745-B721-2CE62A12E902Q38912642-5BB83B20-87E0-4962-8B75-80097815F274Q38950984-7A7EBC8D-031A-4022-A342-BD32A1B56A10Q39026925-1A66DBD6-0685-4BC5-A53E-92C0A0C78627Q39414212-E4D09AF3-8B43-44BB-94C5-72E9DF835D76Q39464111-4A2B94B3-9604-4D3A-ACCB-B5F16A937917Q41661254-C1DAD741-D015-4452-9741-14C3041A5B41Q42712255-74F6A80C-F2BF-43C2-B176-27F944F05F83Q47940580-A452B903-48D8-49BA-89E3-D4A774B5E151Q55018726-D405DE85-ED00-4561-B768-0F5AB5B99C1C
P2860
trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
trans-3,4,5'-Trihydroxystibene ...... in human ovarian cancer cells.
@en
type
label
trans-3,4,5'-Trihydroxystibene ...... in human ovarian cancer cells.
@en
prefLabel
trans-3,4,5'-Trihydroxystibene ...... in human ovarian cancer cells.
@en
P2093
P921
P1476
trans-3,4,5'-Trihydroxystibene ...... in human ovarian cancer cells.
@en
P2093
Zongxian Cao
P304
P356
10.1158/1078-0432.CCR-03-0588
P407
P577
2004-08-01T00:00:00Z